AI-generated summary
This review explores the idea that photobiomodulation, applying specific light wavelengths to body tissues, could reduce Alzheimer's neuropathology and behavioral deficits by controlling hypertension. The authors note that hypertension is linked to Alzheimer's in animal models and in mid-life human risk, and they suggest photobiomodulation could be a preventative and therapeutic option. The abstract presents this as a proposal rather than established evidence.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a narrative review that proposes an idea and does not report any new data or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.